ºÚÁÏÍø±¬³Ô¹Ï

Past Journals Club

December 2025

Mina Sadeghi (presenter) and Prof. Marcel Behr (moderator), December 12th 2025

Paper presented: Proulx MK et al. Noncanonical T cell responses are associated withprotection from tuberculosis in mice and humans. J Exp Med.2025;222(7):e20241760.

November 2025

Luz Villa Castillo (presenter) and Dr. Poshan Thapa (moderator), November 14th, 2025

Paper presented: Liu YE, et al.Ìý²Ñass incarceration as a driver of the tuberculosis epidemic in Latin America and projected effects of policy alternatives: a mathematical modelling study. Lancet Public Health. 2024 Nov;9(11):e841-e851.

October 2025

Kate Harvey (presenter) and Prof. Kevin Schwartzman (moderator), October 24th, 2025

Paper presented: Menzies NA et al. Contribution of Posttuberculosis Sequelae to Life-Years Lost from Tuberculosis Disease in the United States, 2015-2019. Am J Respir Crit Care Med. 2025;211(6):1059-1068.

September 2025

Sammy Robayo Barrios (presenter) and Dr. Jonathon Campbell (moderator), September 26th, 2025

Paper presented: Xin et al. Association of tuberculosis infection with the development of active tuberculosis and comorbidities in rural China: a 10-year follow-up results of a population-based multicentre prospective study. Lancet Reg Health West Pac. 2025;61:101659.

June 2025

Emmanuelle Roy (presenter) and Dr. Marcel Behr (moderator), June 20th, 2025

Paper presented: Nargan et al. Spatial distribution of Mycobacterium tuberculosis mRNA and secreted antigens in acid-fast negative human antemortem and resected tissue. eBioMedicine 2024;105:105196

May 2025

Anne-Marie Farhat (presenter) and Dr. Stephanie Law (moderator), May 23rd, 2025

Paper presented: Shewamene et al. Facilitators and barriers to - uptake of digital adherence technologies in improving TB care in Ethiopia: A qualitative study. PLOS Digital Health 2024;3(11): e0000667.

February 2025

Dr. Fajri Gafar (presenter) and Dr. Dick Menzies (moderator), February 21st, 2025

Paper presented: Guglielmetti L, et al. Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis. N Engl J Med. 2025;392(5):468-482.

January 2025

Suvesh Shrestha (presenter) and Amrita Daftary (moderator), January 31st, 2025

Paper presented: Ryckman T, et al. Impact and cost-effectiveness of short-course tuberculosis preventive treatment for household contacts and people with HIV in 29 high-incidence countries: a modelling analysis. Lancet Glob Health. 2023;11(8):e1205-e1216.

Discover ºÚÁÏÍø±¬³Ô¹Ï International TB Centre

Team    Research    Resources

    Team                                Research                          Resources

Back to top